It was shown that HCC tissues obtained from patients with sorafenib resistance exhibited elevated levels of CASC11 and SLC7A11 expression, in comparison to those obtained from patients with sorafenib sensitivity (Fig. 3M, N). The gene discussed is SLC7A11; the disease is hepatocellular carcinoma.